Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia: A survey of pediatric oncology centers

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Time-to-antibiotic administration (TTA) has been suggested as a quality-of-care (QOC) measure for pediatric oncology patients with febrile neutropenia (FN). Unknown, however, is to what extent pediatric oncology centers utilize TTA. Therefore, we designed and administered an electronic survey (68% response rate) of programs in the Children's Oncology Group to assess TTA utilization. Nearly half of respondents track TTA. Most reported using a benchmark of less than 60min from arrival. TTA is a commonly used QOC measure for pediatric FN despite an absence of studies establishing its validity and a lack of data supporting its impact on outcomes of FN.

Original languageEnglish (US)
Pages (from-to)303-305
Number of pages3
JournalPediatric Blood and Cancer
Volume58
Issue number2
DOIs
StatePublished - Feb 2012

Fingerprint

Febrile Neutropenia
Quality of Health Care
Pediatrics
Anti-Bacterial Agents
Benchmarking
Surveys and Questionnaires

Keywords

  • Febrile neutropenia
  • Prevalence
  • Quality of care
  • Time-to-antibiotics

ASJC Scopus subject areas

  • Oncology
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

@article{d62b13c8745d4c76acaef1eaea6e18f3,
title = "Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia: A survey of pediatric oncology centers",
abstract = "Time-to-antibiotic administration (TTA) has been suggested as a quality-of-care (QOC) measure for pediatric oncology patients with febrile neutropenia (FN). Unknown, however, is to what extent pediatric oncology centers utilize TTA. Therefore, we designed and administered an electronic survey (68{\%} response rate) of programs in the Children's Oncology Group to assess TTA utilization. Nearly half of respondents track TTA. Most reported using a benchmark of less than 60min from arrival. TTA is a commonly used QOC measure for pediatric FN despite an absence of studies establishing its validity and a lack of data supporting its impact on outcomes of FN.",
keywords = "Febrile neutropenia, Prevalence, Quality of care, Time-to-antibiotics",
author = "McCavit, {Timothy L.} and Naomi Winick",
year = "2012",
month = "2",
doi = "10.1002/pbc.23148",
language = "English (US)",
volume = "58",
pages = "303--305",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Time-to-antibiotic administration as a quality of care measure in children with febrile neutropenia

T2 - A survey of pediatric oncology centers

AU - McCavit, Timothy L.

AU - Winick, Naomi

PY - 2012/2

Y1 - 2012/2

N2 - Time-to-antibiotic administration (TTA) has been suggested as a quality-of-care (QOC) measure for pediatric oncology patients with febrile neutropenia (FN). Unknown, however, is to what extent pediatric oncology centers utilize TTA. Therefore, we designed and administered an electronic survey (68% response rate) of programs in the Children's Oncology Group to assess TTA utilization. Nearly half of respondents track TTA. Most reported using a benchmark of less than 60min from arrival. TTA is a commonly used QOC measure for pediatric FN despite an absence of studies establishing its validity and a lack of data supporting its impact on outcomes of FN.

AB - Time-to-antibiotic administration (TTA) has been suggested as a quality-of-care (QOC) measure for pediatric oncology patients with febrile neutropenia (FN). Unknown, however, is to what extent pediatric oncology centers utilize TTA. Therefore, we designed and administered an electronic survey (68% response rate) of programs in the Children's Oncology Group to assess TTA utilization. Nearly half of respondents track TTA. Most reported using a benchmark of less than 60min from arrival. TTA is a commonly used QOC measure for pediatric FN despite an absence of studies establishing its validity and a lack of data supporting its impact on outcomes of FN.

KW - Febrile neutropenia

KW - Prevalence

KW - Quality of care

KW - Time-to-antibiotics

UR - http://www.scopus.com/inward/record.url?scp=83455166627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455166627&partnerID=8YFLogxK

U2 - 10.1002/pbc.23148

DO - 10.1002/pbc.23148

M3 - Article

C2 - 21509930

AN - SCOPUS:83455166627

VL - 58

SP - 303

EP - 305

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 2

ER -